Vincerx Pharma

Filed a patent for "combination therapies comprising a cdk9 inhibitor for multiple myeloma" on Wed, November 2, 2022

Filed a patent for "combination therapies comprising a cdk9 inhibitor for multiple myeloma" on Fri, December 9, 2022

Filed a patent for "combination therapies comprising a cdk9 inhibitor for cancer" on Fri, March 10, 2023

Filed a patent for "combination therapies comprising a cdk9 inhibitor for cancer" on Thu, April 13, 2023

Filed a patent for "selective cdk9 inhibitor for the treatment of a ras mutant cancer" on Wed, January 24, 2024

Filed a patent for "compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorders" on Wed, April 3, 2024

Filed a patent for "compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorders" on Wed, April 3, 2024

Filed a patent for "compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorder" on Wed, April 3, 2024